Galecto

Origo Biopharma

This clinical-stage biotechnology company develops small molecule therapies targeting the transforming growth factor beta pathway to treat fibrosis and cancer in healthcare patients.

Alevin Therapeutics

This biotechnology company develops small molecule integrin inhibitors to treat patients with life-threatening fibrotic diseases, including lung, liver and kidney conditions.

Graviton Bioscience Corporation

The company develops small-molecule therapeutics targeting autoimmune, fibrotic and central nervous system diseases for patients with unmet medical needs.

innovothera

This biotechnology company develops small-molecule therapies for fibrosis, inflammatory diseases, and cancer using an artificial intelligence drug discovery platform.

Veralox

This biotechnology company develops small-molecule therapeutics to treat inflammatory hematologic diseases and type 1 diabetes for patients with unmet medical needs.

Endeavor BioMedicines

This clinical-stage biotechnology company develops small-molecule inhibitors and therapies for patients with oncology and fibrotic lung diseases.

Galera

This biopharmaceutical company develops small-molecule therapies to reduce the side effects of radiotherapy and improve treatment outcomes for patients with advanced breast cancer.

Redx Pharma

This clinical-stage biotechnology company develops small molecule medicines for fibrotic diseases and oncology for pharmaceutical partners and patients with unmet medical needs.